Aug 2006, Vol. 6, No. 4: 592-605
Full Paper
Bacterial spores have been considered as microbial life that could survive interplanetary transport by natural impact processes or human spaceflight activity. Deposition of terrestrial microbes or their biosignature molecules onto the surface of Mars could negatively impact life detection experiments and planetary protection measures. Simulated Mars solar radiation, particularly the ultraviolet component, has been shown to reduce spore viability, but its effect on spore germination and resulting production of biosignature molecules has not been explored. We examined the survival and germinability of Bacillus subtilis spores exposed to simulated martian conditions that include solar radiation. Spores of B. subtilis that contain luciferase resulting from expression of an sspB-luxAB gene fusion were deposited on aluminum coupons to simulate deposition on spacecraft surfaces and exposed to simulated Mars atmosphere and solar radiation. The equivalent of 42 min of simulated Mars solar radiation exposure reduced spore viability by nearly 3 logs, while germination-induced bioluminescence, a measure of germination metabolism, was reduced by less than 1 log. The data indicate that spores can retain the potential to initiate germination-associated metabolic processes and produce biological signature molecules after being rendered nonviable by exposure to Mars solar radiation.
About Astrobiology and The Astrobiology Web
Astrobiology is the leading peer-reviewed journal in its field. To promote this developing field, the Journal has teamed up with The Astrobiology Web to highlight one outstanding paper per issue of Astrobiology. This paper is available free online at www.liebertpub.com/ast and to visitors of The Astrobiology Web at www.astrobiology.com.
Astrobiology is published quarterly in print and online. The journal provides a forum for scientists seeking to advance our understanding of life’s origins, evolution, distribution and destiny in the universe. A complete table of contents and a full text for this issue may be viewed online at www.liebertpub.com/ast.
Mary Ann Liebert, Inc., is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research. Its biotechnology trade magazine, Genetic Engineering News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 60 journals, books, and newsmagazines is available at www.liebertpub.com
Mary Ann Liebert, Inc. - 140 Huguenot St., New Rochelle, NY 10801-5215 - www.liebertpub.com - Phone: (914) 740-2100 - (800) M-LIEBERT - Fax: (914) 740-2101
